• About
  • Blog
  1. Home
  2. Blog
  3. Companies
  4. DHR

Danaher Corporation(DHR)

New York Stock Exchange
Sector: Healthcare | Industry: Medical - Diagnostics & Research
Danaher Corporation logo

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Latest News & Analysis

Danaher Corporation Q2 2025 Earnings & CFO Transition: Strategic Insights and Market Impact
Jul 28, 2025

Danaher Corporation Q2 2025 Earnings & CFO Transition: Strategic Insights and Market Impact

Analyze Danaher's Q2 2025 earnings, CFO transition, and segment performance with detailed financial metrics and market context for informed investment decisions.

Read more →
Danaher Corporation Q2 2025 Analysis: Earnings Beat, Bioprocessing Strength, and AI Innovation
Jul 28, 2025

Danaher Corporation Q2 2025 Analysis: Earnings Beat, Bioprocessing Strength, and AI Innovation

Danaher's Q2 2025 earnings beat expectations with 8% revenue growth and AI-driven diagnostics innovation, highlighting strong fundamentals and strategic growth.

Read more →
Two scientists work with high-tech medical devices in a laboratory with subtle purple lighting
Jul 18, 2025

Danaher Corporation Q2 2025 Analysis: AI Growth, Precision Medicine & Strategic Outlook

Explore Danaher Corporation's latest Q2 2025 developments, AI-driven precision medicine advances, financial performance, and valuation outlook.

Read more →
Laboratory scientists examining high-tech equipment in a sleek lab with a soft purple background
Jul 4, 2025

Danaher Corporation Q2 2025 Update: Bioprocessing Growth, AI Integration & Diagnostics Innovation

Danaher's Q2 2025 analysis reveals robust bioprocessing demand, strategic AI adoption under Martin Stumpe, and mixed diagnostics results shaping future growth.

Read more →
Laboratory scientist working with high-tech instruments in a modern lab with purple accents
Jun 30, 2025

Danaher Corporation (DHR) Strategic AI Growth and Financial Insights - Monexa AI

Danaher Corporation's AI-driven innovation in Life Sciences & Diagnostics boosts growth with strong bioprocessing demand and cost optimization efforts.

Read more →
Confident female scientist with digital screens and imaging devices in a softly lit laboratory
Jun 27, 2025

Danaher's AI Strategy: Revolutionizing Life Sciences & Diagnostics

Uncover Danaher's aggressive AI strategy, spearheaded by Martin Stumpe, focusing on AI diagnostics and precision medicine to drive growth in life sciences.

Read more →
Laboratory scientist reviewing digital data in a modern medical research facility
Jun 23, 2025

Danaher's AI Diagnostics Revolution: Powering Precision Medicine and Q2 Earnings Growth

Danaher's strategic pivot to AI diagnostics and precision medicine, driven by the AstraZeneca partnership. Explore DHR stock outlook, SCIEX innovation, and key Q2 earnings indicators for institutional investors.

Read more →
Image depicting Danaher's strategic innovation in life sciences, featuring advancements in mass spectrometry, AI-powered diagnostics, and an overview of their financial performance and growth.
Jun 11, 2025

Danaher (DHR): Strategic Innovations, Partnerships, and Financial Health

Explore Danaher's strategic moves in 2025, including groundbreaking innovations and partnerships, and analyze their impact on financial performance and market position.

Read more →
Danaher's Strategic Push in Diagnostics & AI: Financial Implications
Jun 5, 2025

Danaher's Strategic Push in Diagnostics & AI: Financial Implications

Danaher accelerates diagnostics innovation with ZenoTOF 8600 launch & partnerships with AstraZeneca and Evosep, positioning for growth in AI and precision medicine.

Read more →
Abstract visual representing biotech innovation and financial growth, serving as a header for an article discussing Danaher's role as a gene editing enabler and its market performance analysis.
May 28, 2025

Danaher (DHR) Analysis: Biotech Breakthroughs and Financial Strategy

Danaher's latest moves: Prime Medicine's clinical success, strategic share buybacks, and solid financials position DHR for future growth amid evolving biotech landscape.

Read more →
Analysis of Danaher Corporation (DHR) stock performance, financial results, and strategic outlook in the life sciences and diagnostics industry.
May 28, 2025

Danaher Corporation (DHR) Financial Analysis & Key Developments

Recent market analysis reveals a decline in Danaher's stock value following its latest earnings report, prompting investor scrutiny. This analysis delves into DHR's financial health, strategic moves, and the impact of breakthrough gene therapy data on its market position.

Read more →
Danaher (DHR) Stock Analysis: Navigating Market Challenges and Strategic Outlook
Apr 9, 2025

Danaher (DHR): Diagnostics Strength Amidst Life Sciences Challenges

Danaher (DHR) faces headwinds in life sciences but sees strength in diagnostics and Abcam. Cost optimization and shareholder returns are key.

Read more →
Danaher (DHR) stock analysis: Navigating life science challenges, diagnostics growth, and AI integration. Is it a buying opportunity?
Mar 24, 2025

Danaher (DHR): Life Sciences Challenges & Diagnostics Growth

Danaher Corporation (DHR) navigates Life Sciences headwinds with strategic growth in diagnostics, AI, and industrial lasers. A potential buying opportunity arises near its 5-year low.

Read more →
Danaher (DHR) Stock Analysis: Diagnostics advancements, AI integration, and financial performance insights for investors. Stay informed about DHR's market outlook and strategic initiatives.
Mar 10, 2025

Danaher (DHR): FDA Clearance, AI Strategy, and Market Outlook

Danaher's strategic moves, including FDA clearance for its DxC 500i analyzer and AI integration, are set against a backdrop of tempered growth forecasts and market volatility.

Read more →
Danaher's Strategic Growth: Dividend Increase, AI Integration, and Market Performance Analysis
Mar 6, 2025

Danaher Corporation: Dividend Growth and Strategic Financial Update

A deep dive into Danaher's dividend increase, AI board appointment, and market performance driving strategic growth.

Read more →
Danaher Corporation: Dividend increase, AI integration, molecular diagnostics, and industrial laser marking analysis for investors.
Feb 28, 2025

Danaher (DHR): Dividend, AI Strategy, and Market Growth Analysis

Danaher's dividend increase, AI strategy, and key market positions drive shareholder value. A comprehensive analysis of DHR's growth and stability.

Read more →
Danaher Corporation: Analysis of dividend increase, AI integration with Charles Lamanna, molecular diagnostics market position, and industrial laser expansion.
Feb 27, 2025

Danaher (DHR): Dividend, AI, and Market Expansion – A Comprehensive Analysis

Danaher navigates a dynamic market with AI, molecular diagnostics, and laser marking strategies. An increased dividend signals strength. Challenges include market volatility.

Read more →
Danaher's strategic shift: Dividends, AI, and market growth analysis.
Feb 26, 2025

Danaher's Strategic Shift: Dividends, AI, and Market Growth

Danaher strategically shifts towards AI, boosts dividends, and targets market growth in diagnostics and laser marking, signaling robust future prospects.

Read more →
Danaher (DHR) stock analysis: Dividend increase, AI strategy with Charles Lamanna, growth in molecular infectious disease testing, and market performance. Insights for investors.
Feb 25, 2025

Danaher (DHR): Dividend, AI Strategy, and Market Growth Analysis

Danaher (DHR) balances dividend growth, AI strategy, and market expansion amid volatility. Key is infectious disease testing and laser marking market growth.

Read more →
Danaher's strategic shift: AI integration, dividend boost, and growth prospects in life sciences and molecular diagnostics. Explore DHR's financial health and future outlook.
Feb 21, 2025

Danaher: Dividend Hike, AI Push, and Navigating Market Uncertainty

Explore Danaher's strategic developments including an 18.5% dividend increase and board appointment that drive market impact.

Read more →
Danaher's strategic shift: AI integration, dividend boost, and market opportunities in life sciences and diagnostics. Investment analysis and stock insights.
Feb 21, 2025

Danaher's Strategic Shift: AI Integration, Dividend Boost

Danaher Corporation (DHR) sees strategic shifts with a new board member, increased dividends, and a strong position in molecular diagnostics.

Read more →
Danaher Corporation logo with laboratory equipment background.
Feb 18, 2025

Danaher Corporation: Navigating Market Challenges in 2025

A comprehensive data-driven analysis of Danaher Corporation’s intraday market performance, earnings, and strategic shifts in 2025.

Read more →
Futuristic lab showcasing Danaher's interconnected molecular diagnostics, highlighting innovation in life sciences.
Feb 13, 2025

Danaher Corporation: Strategic Shifts Amid Biotech Headwinds

A forward-looking analysis of Danaher’s strategic moves amid biotech challenges and expanding molecular diagnostics opportunities.

Read more →

Professional-grade financial analysis tools for informed investment decisions.

Product

  • Features
  • Pricing

Resources

  • Blog
  • Knowledge Base
  • Community
  • Market Data

Company

  • About
  • Careers
  • Contact
  • Partners

Legal

  • Privacy
  • Terms
  • License
  • Security

© 2025 Monexa. All rights reserved. Market data provided by financial exchanges and may be delayed as specified by financial exchanges or our data providers.